Biomarker Menu
Biomarker Menu

Explore Our Biomarker Menu

Including 400+ Biomarker Offerings for a Range of Disease States

Return to Biomarker Menu

Biomarker: IL-12-p70

Search for Biomarkers

Analyte:

IL-12-p70

Platform:

Matrix:

Human Serum

Disease State:

null

Status:

Offered

Required Sample Volume:

null

Sensitivity-LLOQ/ULOQ:

LLOQ: 0.460 pg/mL

Biological or Clinical Significance:

Interleukin-12 p70 (IL-12p70) heterodimer, composed of p35 and p40 subunits, is a major Th1-driving cytokine, promoting cell-mediated immunity. Inability of TNFa/PGE2 to induce IL-12p70 strongly enhances the lipopolysaccharide (LPS)–induced IL-12p70 production. In addition to the selective induction of IL-12p40 in TNFa-stimulated DCs, PGE2 inhibits the production of IL-12p70 in DCs stimulated with LPS or CD40 ligand. Suppression of bioactive IL-12p70 may have negative impact on anticancer
vaccination with PGE2-matured DCs.

References:

Speak to a Scientist












What would you like to discuss?

With whom will we be speaking?






I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.









biomarker services

Services

See how our premier bioanalytical services support all phases of biomarker, immunogenicity, PK, and cell-based assay studies.

Explore our services

case studies

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Read our case studies